Questcor Strengthens Management Team's Manufacturing and Commercial Operations Capabilities Sep 5, 2008
Source: Questcor Pharmaceuticals ... Sept. 5, 2008 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (NasdaqCM: - ) announced today that it has recently expanded its management team with the appointment of Timothy O'Neill, Ph ... Questcor Pharmaceuticals, Inc. is a pharmaceutical company that markets two commercial products, H.P. Acthar(r) Gel (``Acthar'') and Doral(r). (Primezone Releases)
Drug prices up 100%, or higher; Spikes bring legal, political scrutiny... Aug 9, 2008
Among the examples: Questcor Pharmaceuticals last August raised the wholesale price on Acthar, which treats spasms in babies, from about $1,650 a vial to more than $23,000. Ovation raised the cost of Cosmegen, which treats a type of tumor, from $16. (The Drudge Report)
Life-Saving Drug's Price Hike Hits Family Hard Sep 3, 2007
It's maker, Questcor Pharmaceuticals, just raised the price from $1,600 a vial to $23,000 a vial, and the cost is not covered by insurance. "We've never had to ask for help," Tyler's mother Christina said. (CBS 4, CO)
Questcor Pharmaceuticals narrows Q2 loss Aug 10, 2007
Questcor Pharmaceuticals Inc. Thursday reported a second-quarter net loss of $1. 7 million, or 2 cents per share, down from a loss of $2. (East Bay Business Times, CA)
Questcor Pharmaceuticals' Q1 revenue up May 12, 2007
Members: Not Registered. for free extra services. (East Bay Business Times, CA)
FDA warns of rare, odd reactions to sleep drugs Mar 15, 2007
In addition to Ambien, made by Sanofi-Aventis, and Lunesta (Sepracor), the FDA listed the affected drugs as Butisol Sodium (MedPointe Pharmaceuticals), Carbrital (Parke-Davis), Dalmane (Valeant Pharmaceuticals), Doral (Questcor Pharmaceuticals), Halcion (Pharmacia & Upjohn), Placidyl (Abbott), ProSom (Abbott), Restoril (Tyco Healthcare), Rozerem (Takeda), Seconal (Eli Lilly), and Sonata (King Pharmaceuticals). The companies were told to. (Philadelphia Inquirer)
